Abstract:Genome-wide association studies (GWASs) have identified dozens of susceptibility loci for sporadic Alzheimer's disease (AD) primarily in Caucasians, but whether the same or different variants account for genetic risks in Chinese remains unknown. A two-stage case-control GWAS was conducted for subjects from 39 hospitals across China. In the discovery stage, 993 AD cases and 6,451 controls passed quality control after genotyping using Illumina HumanOmniZhongHua-8 BeadChips. In the replication stage, 55 top single nucleotide polymorphisms (SNPs) with evidence of associations and eight SNPs previously reported in Caucasians were selected for genotyping using ABI PRISM® SNaPshot™ Multiplex System in an independent cohort of 1,201 AD cases and 4,889 controls. In the combined analysis, seven SNPs had associations exceeding the genome-wide significance threshold (P < 5.0 × 10−8) with no heterogeneity between stages. The overall variance was calculated using the restricted maximum-likelihood method. HaploReg, cis-expression quantitative trait loci (cis-eQTL) database, the Gene Expression Omnibus (GEO) profiles, STRING, and the Gene Ontology enrichment analysis was used to further characterize these seven variants. For the APOE region, multifactor regression analysis using imputed data was performed. Four novel variants were identified with genome-wide significance (P < 5 × 10-8): rs463717 (5q31.3, Pcombined = 8.56 × 10-15), rs11625699 (14q13.1, Pcombined = 4.80 × 10-20), rs3784616 (15q21.1, Pcombined = 2.34 × 10-25), and rs16980322 (19q13.32, Pcombined = 2.75 × 10-21). Additionally, APOE rs405509 (Pcombined = 9.53 × 10-28), PVRL2 rs4803766 (Pcombined = 1.91 × 10-18), and PVRL2 rs387976 (Pcombined = 9.90 × 10-11) were associated with AD. These seven variants explained 15.87% of the overall variance in disease risk. For the eight previously reported SNPs selected for detection in the replication stage, only rs2070045 of SORL1 showed significant associations. Multifactor regression analysis using imputed data in APOE region found previously reported AD-associated SNPs in Caucasians remained significant in Chinese. The present GWAS identified four novel susceptibility variants for AD. The genes located near the four novel variants are functionally related to neurogenesis, suggesting neurogenesis in AD pathogenesis. This study also suggests genetic heterogeneity of AD susceptibility in Chinese and Caucasian populations. Regional association plots. Association results are shown for the analyzed SNPs with recombination rates in the four loci associated with genome-wide significance at 5q31.3 (a), 14q13.1 (b), 15q21.1 (c) and 19q13.32 (d-e). Purple diamonds represent the most significantly associated SNP in the combined analysis. The quantile-quantile (Q-Q) plot of the association results from the discovery stage analysis (993 AD cases and 6,451 controls). Displayed are observed versus expected -log10 P values for all variants. The yellow line indicates the expected distribution of - log10 P values under the null hypothesis. The plot in purple is for SNPs excluding previously reported SNPs with P > 10-12 (λGC = 1.038).

A Genome-Wide Association Study of Α-Synuclein Levels in Cerebrospinal Fluid

FOUR NOVEL SUSCEPTIBILITY VARIANTS IDENTIFIED IN CHINESE ARE ASSOCIATED WITH SPORADIC ALZHEIMER’S DISEASE

Genome-wide Association Study of Cerebrospinal Fluid Neurofilament Light Levels in Non-Demented Elders.

Cerebrospinal fluid α-synuclein as a potential biomarker for Alzheimer’s disease (P4.174)

A genome-wide association study of longitudinal change in CSF tau among non-demented elderly

Α-Synuclein in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.

Cerebrospinal Fluid Α-Synuclein Predicts Neurodegeneration and Clinical Progression in Non-Demented Elders

Cerebrospinal Fluid α-Synuclein Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer's Disease

Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer's disease

Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning

The Association Between Plasma α-Synuclein (α-syn) Protein, Urinary Alzheimer-Associated Neuronal Thread Protein (AD7c-NTP), and Apolipoprotein Epsilon 4 (ApoE ε4) Alleles and Cognitive Decline in 60 Patients with Alzheimer's Disease Compared with 28 Age-Matched Normal Individuals

α-synuclein as an emerging pathophysiological biomarker of Alzheimer’s disease

Associations between misfolded alpha‐synuclein aggregates and Alzheimer's disease pathology in vivo

Common Variants in PLXNA4 and Correlation to CSF-related Phenotypes in Alzheimer's Disease.

Relation between Alpha-Synuclein and Core CSF Biomarkers of Alzheimer’s Disease

A genetic and proteomic comparison of key AD biomarkers across tissues

Genome-wide association study identifies CD1A associated with rate of increase in plasma neurofilament light in non-demented elders.

X chromosome-wide association study of quantitative biomarkers from the Alzheimer's Disease Neuroimaging Initiative study

Genome-Wide Association and Mechanistic Studies Indicate That Immune Response Contributes to Alzheimer's Disease Development

SNPs Associated with Cerebrospinal Fluid Phospho-Tau Levels Influence Rate of Decline in Alzheimer's Disease

Genome-wide Association Study Identifies CBFA2T3 Affecting the Rate of CSF Aβ42 Decline in Non-Demented Elders.